An andrographolide analogue namely andrographolide-lipoic acid conjugate was reported to lower the blood glucose levels through increasing insulin, preventing loss and dysfunction of islet beta cells and stimulating GLUT-4 membrane translocation in soleus muscles of alloxan-diabetic rats (type 1 diabetic rats) (Zhang et al., 2009).